Foresite Capital Management II’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-523,132
| Closed | -$1.11M | – | 14 |
|
|
2017
Q3 | $1.11M | Sell |
523,132
-78,881
| -13% | -$167K | 0.45% | 11 |
|
|
2017
Q2 | $1.75M | Sell |
602,013
-20,000
| -3% | -$58K | 0.8% | 7 |
|
|
2017
Q1 | $2.14M | Buy |
622,013
+79,258
| +15% | +$273K | 0.92% | 9 |
|
|
2016
Q4 | $944K | Hold |
542,755
| – | – | 0.47% | 8 |
|
|
2016
Q3 | $1.8M | Sell |
542,755
-1
| -0% | -$3 | 0.86% | 9 |
|
|
2016
Q2 | $2.33M | Sell |
542,756
-103,452
| -16% | -$445K | 1.6% | 11 |
|
|
2016
Q1 | $3.64M | Buy |
646,208
+23,703
| +4% | +$133K | 1.78% | 13 |
|
|
2015
Q4 | $10.7M | Buy |
622,505
+200,000
| +47% | +$3.44M | 3.59% | 9 |
|
|
2015
Q3 | $8.92M | Buy |
422,505
+2,500
| +0.6% | +$52.8K | 2.71% | 11 |
|
|
2015
Q2 | $20.8M | Hold |
420,005
| – | – | 7.3% | 6 |
|
|
2015
Q1 | $32.9M | Buy |
420,005
+18,238
| +5% | +$1.43M | 19.48% | 2 |
|
|
2014
Q4 | $24.3M | Buy |
+401,767
| New | +$24.3M | 16.67% | 2 |
|